|
|
| Model Number |
TCM1510X3 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Abdominal Pain (1685); Emotional Changes (1831); Pain (1994); Scar Tissue (2060); Scarring (2061); Distress (2329); Discomfort (2330); Injury (2348); Disability (2371); Abdominal Distention (2601); Unspecified Gastrointestinal Problem (4491); Unspecified Tissue Injury (4559)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a right direct and right femoral hernia.It was reported that after implant, the patient experienced abdominal pain, bulging, bowel issues, keloid scarring, pain, suffering, disability, impairment, loss of enjoyment of life, loss of care, loss of comfort, and distress.Post-operative patient treatment included revision surgery, excision of keloid scar, and trigger point kenalog injection.
|
| |
|
Additional Manufacturer Narrative
|
|
(model #, catalog #, expiration date, lot #, udi #), d8, e1 (facility name, street, city, region, postal code), g4 (510k #), h6 (patient codes, imf codes).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a right direct and right femoral hernia.It was reported that after implant, the patient experienced abdominal pain, bulging, bowel issues, keloid scarring, pain, suffering, disability, impairment, loss of enjoyment of life, and distress.Post-operative patient treatment included revision surgery, hernia revision, excision of keloid scar, trigger point kenalog injection, open herniorrhaphy, removal of mesh and inguinal floor reconstruction.
|
| |
|
Additional Manufacturer Narrative
|
|
Correction: b2 (added disability).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|